Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Prestige Consumer Healthcare Inc., 3 years.
Prestige Consumer Healthcare Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 4, 2026 | Prestige Consumer Healthcare Inc. | Grant or award | +2,981 | — | — |
| May 15, 2026 | Haemonetics Corporation | Shares withheld for tax | −2,505 | $56.29 | $141,006 |
| May 15, 2026 | Haemonetics Corporation | Grant or award | +29,312 | — | — |
| May 1, 2026 | Haemonetics Corporation | Shares withheld for tax | −655 | $59.26 | $38,815 |
| Aug 5, 2025 | Prestige Consumer Healthcare Inc. | Grant or award | +2,094 | — | — |
| May 30, 2025 | Haemonetics Corporation | Grant or award | +12,221 | — | — |
| May 30, 2025 | Haemonetics Corporation | Shares withheld for tax | −5,864 | $69.38 | $406,844 |
| May 16, 2025 | Haemonetics Corporation | Grant or award | +7,111 | — | — |
| May 16, 2025 | Haemonetics Corporation | Shares withheld for tax | −1,246 | $70.31 | $87,606 |
| May 15, 2025 | Haemonetics Corporation | Shares withheld for tax | −622 | $69.38 | $43,154 |
| May 2, 2025 | Haemonetics Corporation | Shares withheld for tax | −654 | $63.85 | $41,758 |
| Aug 6, 2024 | Prestige Consumer Healthcare Inc. | Grant or award | +2,202 | — | — |
| May 17, 2024 | Haemonetics Corporation | Grant or award | +4,439 | — | — |
| May 16, 2024 | Haemonetics Corporation | Shares withheld for tax | −351 | $94.80 | $33,275 |
| May 15, 2024 | Haemonetics Corporation | Shares withheld for tax | −412 | $96.49 | $39,754 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.